heterozygous familial hyperlipidemia
DBCOND0106235Nutritional and Metabolic Diseases
heterozygous familial hyperlipidemia is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.
- Classified under
- Indicated drugs
What you can answer from here — as of October 23, 2026
1Indicated drugWith each drug's targets and mechanismListed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not proseSign in
Which approved drugs for heterozygous familial hyperlipidemia share a target, and which companies have late-stage candidates against it?
Create a free account or log in to explore the full data card.
Create Account